Comparison of visual outcomes of polypoidal choroidal vasculopathy and typical neovascular age‐related macular degeneration—up to 10 years of follow‐up-Reference-Cited by-同舟云学术

Comparison of visual outcomes of polypoidal choroidal vasculopathy and typical neovascular age‐related macular degeneration—up to 10 years of follow‐up

Published:2022-04 Issue:8 Volume:100 Page:
ISSN:1755-375X
Container-title:Acta Ophthalmologica
language:en
Short-container-title:Acta Ophthalmologica

Author:

Park Jun Young¹²^ORCID,Park Young Joo¹³^ORCID,Park Sang Jun¹^ORCID,Park Kyu Hyung¹^ORCID,Yeo Joon Hyung⁴,Kim June‐Gone⁵,Yoon Young Hee⁵^ORCID,Lee Joo Yong⁵^ORCID,Woo Se Joon¹^ORCID

Affiliation:

1. Department of Ophthalmology Seoul National University Bundang Hospital, Seoul National University College of Medicine Seongnam South Korea

2. Department of Ophthalmology Uijeongbu Eulji Medical Center, Eulji University School of Medicine Uijeongbu South Korea

3. Department of Ophthalmology Kangwon National University Hospital, Kangwon National University Graduate School of Medicine Chuncheon South Korea

4. Department of Ophthalmology Chung‐Ang University Gwangmyeong Hospital, Chung‐Ang University College of Medicine Gwangmyeong South Korea

5. Department of Ophthalmology, Asan Medical Center University of Ulsan, College of Medicine Seoul South Korea

Funder

Seoul National University Bundang Hospital

Publisher

Wiley

Subject

Ophthalmology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/aos.15149

Reference27 articles.

1. Ranibizumab versus Verteporfin Photodynamic Therapy for Neovascular Age-Related Macular Degeneration: Two-Year Results of the ANCHOR Study

2. Polypoidal Choroidal Vasculopathy

3. A Multicountry Comparison of Real-World Management and Outcomes of Polypoidal Choroidal Vasculopathy

4. Long-Term Outcomes of Treatment of Neovascular Age-Related Macular Degeneration

5. Ranibizumab and Bevacizumab for Neovascular Age-Related Macular Degeneration

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long‐term efficacy and safety of brolucizumab in neovascular age‐related macular degeneration: A multicentre retrospective real‐world study;Acta Ophthalmologica;2024-05-05

2. Efficacy and safety of intravitreal faricimab for neovascular age-related macular degeneration: a systematic review and meta-analysis;Scientific Reports;2024-01-30

3. Efficacy, durability, and safety of faricimab in patients from Asian countries with neovascular age-related macular degeneration: 1-Year subgroup analysis of the TENAYA and LUCERNE trials;Graefe's Archive for Clinical and Experimental Ophthalmology;2023-06-09

4. Twenty-year outcome in neovascular age-related macular degeneration treated with photodynamic therapy and intravitreal bevacizumab/ranibizumab injections: A case report;Photodiagnosis and Photodynamic Therapy;2023-06